Genmab A/S
OTC:GNMSF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genmab A/S
OTC:GNMSF
|
DK |
|
R
|
Relx PLC
F:RDEB
|
UK |
|
M
|
Mattel Inc
XMUN:MTT
|
US |
Wall St Price Targets
GNMSF Price Targets Summary
Genmab A/S
According to Wall Street analysts, the average 1-year price target for GNMSF is 389.77 USD with a low forecast of 216.13 USD and a high forecast of 470.25 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GNMSF's stock price target?
Price Target
389.77
USD
According to Wall Street analysts, the average 1-year price target for GNMSF is 389.77 USD with a low forecast of 216.13 USD and a high forecast of 470.25 USD.
What is the Revenue forecast for Genmab A/S?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Genmab A/S?
Projected CAGR
7%
The compound annual growth rate for Gross Profit over the next 8 years is 7%.
What is the Operating Income forecast for Genmab A/S?
Projected CAGR
10%
The compound annual growth rate for Operating Income over the next 8 years is 10%.
What is the Pre-Tax Income forecast for Genmab A/S?
Projected CAGR
20%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 20%.
What is the Net Income forecast for Genmab A/S?
Projected CAGR
12%
The compound annual growth rate for Net Income over the next 8 years is 12%.